Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance
- PMID: 27382922
- DOI: 10.2214/AJR.16.16064
Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance
Abstract
Objective: The objective of our study was to evaluate recurrence patterns of upper tract transitional cell carcinomas (UT-TCCs) after radical nephroureterectomy (RNU).
Materials and methods: Sixty-eight patients (mean age, 78 years; 34 men and 34 women) with UT-TCC after having undergone RNU from 2001 to 2008 were included in this study. Radiologic examinations and clinical notes were reviewed to record tumor location, tumor morphology, histologic T stages and grades, lymphovascular invasion (LVI) status, and surgical procedures. Five-year imaging and clinical follow-up (2001-2013) findings were noted at 3, 6, 12, 18, 24, 36, 48, 60, and more than 60 months after RNU for recurrence pattern and tumor-free survival. Kaplan-Meier survival curves and Cox regression models were used to assess tumor-free survival and to perform a multivariate analysis.
Results: Forty-one postoperative recurrences were noted in 20 patients. The mean time to relapse was 16 months, and time to relapse ranged from 1 to 66 months. Tumor site (multifocal lesions involving both renal collecting system and ureter), tumor morphology (mass), T stage (muscle invasion [T2-T4]), histologic grade (grade 3), and the presence of LVI were identified as risk factors for postoperative recurrence in UT-TCC. T stage was the only independent risk factor.
Conclusion: Urinary tract, lymph node, liver, bone, and lung recurrences were common in patients with UT-TCC and were detected most frequently at 3-24 months. Tumor site, tumor morphology, T stage, grade, and LVI status were associated with recurrence after RNU. T stage was the only independent predictor of tumor-free survival. Close surveillance for extra-urinary tract recurrences in high-risk groups and a shorter-interval follow-up of the urinary tract in low-risk patients with adjuvant chemotherapy are recommended. Identifying recurrence patterns in UT-TCC can aid in planning an effective tailored imaging surveillance strategy.
Keywords: cell carcinoma; nephroureterectomy; recurrence; transitional cell carcinoma; upper tract; upper tract transitional.
Comment in
-
Re: Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.J Urol. 2017 May;197(5):1216-1217. doi: 10.1016/j.juro.2017.02.002. Epub 2017 Feb 7. J Urol. 2017. PMID: 29539888 No abstract available.
Similar articles
-
Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.Korean J Urol. 2015 Jan;56(1):41-7. doi: 10.4111/kju.2015.56.1.41. Epub 2015 Jan 6. Korean J Urol. 2015. PMID: 25598935 Free PMC article.
-
Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.Urology. 2005 Apr;65(4):692-6. doi: 10.1016/j.urology.2004.11.001. Urology. 2005. PMID: 15833510
-
Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.BJU Int. 2012 Sep;110(6):798-803. doi: 10.1111/j.1464-410X.2011.10893.x. Epub 2012 Feb 7. BJU Int. 2012. PMID: 22313599
-
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3. BJU Int. 2012. PMID: 22471401 Review.
-
Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.BJU Int. 2007 Jul;100(1):11-6. doi: 10.1111/j.1464-410X.2007.06841.x. Epub 2007 Apr 8. BJU Int. 2007. PMID: 17428248 Review.
Cited by
-
Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma.Front Oncol. 2022 Feb 24;12:791140. doi: 10.3389/fonc.2022.791140. eCollection 2022. Front Oncol. 2022. PMID: 35280720 Free PMC article.
-
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.Front Oncol. 2021 Nov 25;11:731905. doi: 10.3389/fonc.2021.731905. eCollection 2021. Front Oncol. 2021. PMID: 34900681 Free PMC article.
-
Rapid recurrence of squamous cell carcinoma at a lymphocele after nephroureterectomy: A rare case report.IJU Case Rep. 2021 Feb 15;4(2):118-121. doi: 10.1002/iju5.12259. eCollection 2021 Mar. IJU Case Rep. 2021. PMID: 33718823 Free PMC article.
-
Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.Int Urol Nephrol. 2020 Jun;52(6):1043-1048. doi: 10.1007/s11255-020-02396-z. Epub 2020 Jan 29. Int Urol Nephrol. 2020. PMID: 31997062
-
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.World J Urol. 2019 Nov;37(11):2419-2427. doi: 10.1007/s00345-019-02678-x. Epub 2019 Feb 13. World J Urol. 2019. PMID: 30759271
LinkOut - more resources
Full Text Sources
Other Literature Sources
